These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 21368465

  • 21. [Hormonal therapy with aromatase inhibitor in advanced breast cancer].
    Vrbanec D, Belev B, Pavlinić-Diminić V, Pezerović D, Dusper B, Plestina S, Unusić J.
    Lijec Vjesn; 1998; 120(10-11):315-8. PubMed ID: 19658346
    [Abstract] [Full Text] [Related]

  • 22. [A Case of Liver Failure Induced by Toremifene in a Patient with Metastatic Breast Cancer].
    Omoto H, Yamashita S, Ito H.
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1809-11. PubMed ID: 26805180
    [Abstract] [Full Text] [Related]

  • 23. [A case of metastatic breast cancer responding to weekly paclitaxel and high-dose toremifene administrated alternately].
    Murakami H, Noda S, Okamura Y, Sakakibara T, Ishikawa T, Nakamura H, Yaguchi T, Harada A.
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):1963-6. PubMed ID: 12465396
    [Abstract] [Full Text] [Related]

  • 24. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
    Ellis MJ, Tao Y, Luo J, A'Hern R, Evans DB, Bhatnagar AS, Chaudri Ross HA, von Kameke A, Miller WR, Smith I, Eiermann W, Dowsett M.
    J Natl Cancer Inst; 2008 Oct 01; 100(19):1380-8. PubMed ID: 18812550
    [Abstract] [Full Text] [Related]

  • 25. [A case of metastatic breast cancer resistant to anastrozole treatment responding to high-dose toremifene].
    Murata T, Yoshino H, Bandou H, Morita K, Kurokawa M, Inaki N, Kotake M, Kadoya S, Yamamoto M, Takayanagi T, Yamada T.
    Gan To Kagaku Ryoho; 2009 Apr 01; 36(4):671-3. PubMed ID: 19381046
    [Abstract] [Full Text] [Related]

  • 26. Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients.
    Lerouge D, Touboul E, Lefranc JP, Genestie C, Moureau-Zabotto L, Blondon J.
    Int J Radiat Oncol Biol Phys; 2004 Jul 15; 59(4):1062-73. PubMed ID: 15234040
    [Abstract] [Full Text] [Related]

  • 27. Retrospective analysis of concurrent vs. sequential administration of radiotherapy and hormone therapy using aromatase inhibitor for hormone receptor-positive postmenopausal breast cancer.
    Ishitobi M, Komoike Y, Motomura K, Koyama H, Nishiyama K, Inaji H.
    Anticancer Res; 2009 Nov 15; 29(11):4791-4. PubMed ID: 20032437
    [Abstract] [Full Text] [Related]

  • 28. [A case of locally recurrent breast cancer in which phlebothrombosis of the right leg after hormonal therapy using a high dose of toremifene citrate].
    Sakuta M, Sumiyama Y, Okamoto Y, Noto Y, Naka I, Kiribayashi T.
    Gan To Kagaku Ryoho; 2002 Jan 15; 29(1):115-8. PubMed ID: 11816466
    [Abstract] [Full Text] [Related]

  • 29. [A case of premenopausal metastatic breast cancer treated with goserelin plus aromatase inhibitor as second-line endocrine therapy].
    Baba S, Oji Y, Teramoto M, Kawabata K, Saito A.
    Gan To Kagaku Ryoho; 2009 Nov 15; 36(11):1905-6. PubMed ID: 19920398
    [Abstract] [Full Text] [Related]

  • 30. Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis.
    Punglia RS, Kuntz KM, Winer EP, Weeks JC, Burstein HJ.
    J Clin Oncol; 2005 Aug 01; 23(22):5178-87. PubMed ID: 15998905
    [Abstract] [Full Text] [Related]

  • 31. Breast cancer (non-metastatic).
    Rodger A, Stebbing J, Thompson AM.
    Clin Evid; 2006 Jun 01; (15):2360-92. PubMed ID: 16973090
    [No Abstract] [Full Text] [Related]

  • 32. Open phase II study of high-dose toremifene as first-line therapy for advanced breast cancer.
    Hietanen T, Hakala T, Baltina D, Johansson R, Numminen S, Helle L, Valavaara R, Thölix E.
    Oncology (Williston Park); 1997 May 01; 11(5 Suppl 4):37-40. PubMed ID: 9165505
    [Abstract] [Full Text] [Related]

  • 33. [A case of breast cancer patient of CAF (cyclophosphamide, adriamycin, 5-fluorouracil) resistant lung metastasis with remarkable response to reverse drug-resistance by toremifene].
    Kusama M, Kaise H, Nakayama S, Ohta D, Aoki T, Koyanagi Y.
    Gan To Kagaku Ryoho; 1999 Jul 01; 26(8):1171-5. PubMed ID: 10431584
    [Abstract] [Full Text] [Related]

  • 34. Remission of macroglobulinemia during anastrozole treatment for breast cancer.
    Chettle C, Baker MA.
    N Engl J Med; 2005 Apr 21; 352(16):1725-6. PubMed ID: 15843681
    [No Abstract] [Full Text] [Related]

  • 35. The Breast International Group 1-98 trial: big results for women with hormone-sensitive early breast cancer.
    Monnier AM.
    Expert Rev Anticancer Ther; 2007 May 21; 7(5):627-34. PubMed ID: 17492927
    [Abstract] [Full Text] [Related]

  • 36. [A case regarded as an occult breast cancer treated without mastectomy].
    Kawashima T, Miyazawa Y, Sakata H, Matsubara H, Ryu M, Ochiai T.
    Gan To Kagaku Ryoho; 2005 Jun 21; 32(6):825-8. PubMed ID: 15984524
    [Abstract] [Full Text] [Related]

  • 37. Clinical usefulness of high-dose toremifene in patients relapsed on treatment with an aromatase inhibitor.
    Yamamoto Y, Masuda N, Ohtake T, Yamashita H, Saji S, Kimijima I, Kasahara Y, Ishikawa T, Sawaki M, Hozumi Y, Iwase H.
    Breast Cancer; 2010 Oct 21; 17(4):254-60. PubMed ID: 19685269
    [Abstract] [Full Text] [Related]

  • 38. High-dose toremifene vs tamoxifen in postmenopausal advanced breast cancer.
    Gershanovich M, Hayes DF, Ellmén J, Vuorinen J.
    Oncology (Williston Park); 1997 May 21; 11(5 Suppl 4):29-36. PubMed ID: 9165504
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Adverse outcome and resistance to adjuvant antiestrogen therapy in node-positive postmenopausal breast cancer patients-The role of p53.
    Rahko E, Blanco G, Bloigu R, Soini Y, Talvensaari-Mattila A, Jukkola A.
    Breast; 2006 Feb 21; 15(1):69-75. PubMed ID: 16005229
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.